Metabolic health may affect cancer risk in obesity
In a study from Lund University, scientists found metabolic health may play an important role in cancers related to obesity.
In the study, for up...
Widely used dietary supplement causes cancer risk and spread, study finds
Several studies have linked dietary supplements like nicotinamide riboside (NR), a form of vitamin B3, to benefits related to heart, metabolic and brain health.
But...
Ultra-processed foods may increase your cancer risk and death
In a study from Imperial College London and elsewhere, scientists found higher intake of ultra-processed foods may be linked to an increased risk of...
Cancer prevention: Top tips for reducing cancer risk
Many forms of cancer are preventable. Although risk factors such as age or genetics cannot be changed, other risk factors for cancer including healthy...
Ovarian cancer is not a silent killer – recognizing its symptoms could help reduce...
Ovarian cancer is the most deadly of gynecologic tumors.
Fewer than 40% of those diagnosed with ovarian cancer are cured, and approximately 12,810 people in...
This blood pressure drug may benefit people with deadly brain cancer
In a study from Massachusetts General Hospital, scientists found a blood pressure drug may benefit people with deadly brain cancer.
People with glioblastoma—the deadliest type...
Scientists improve treatment for common lung cancer
In a study from Upstate Medical University, scientists did a clinical trial that may have major implications for the treatment of small-cell lung cancer.
The...
Why cancer is especially dangerous to people with type 2 diabetes
In a study from the University of Leicester, scientists found that cancer mortality in people with type 2 diabetes is higher than in the...
Scientists find new way to predict deadly brain cancer
In a study from the University of Waterloo and elsewhere, scientists have created a computational model to predict the growth of deadly brain tumours...
This new test can improve ovarian cancer treatment
Scientists developed a genetic test that can identify ovarian cancer patients who benefit from PARP inhibitors, a treatment option.